Pathophysiology of Post-COVID syndromes: a new perspective von Batiha, Gaber El-Saber, Al-Kuraishy, Hayder M, Al-Gareeb, Ali I, Welson, Nermeen N

Volltext

The potential role of neopterin in Covid-19: a new perspective von Al-kuraishy, Hayder M., Al-Gareeb, Ali I., Alzahrani, Khalid J., Cruz-Martins, Natália, Batiha, Gaber El-Saber

Volltext

Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity von Al-kuraishy, Hayder M., Al-Gareeb, Ali I., Almulaiky, Yaaser Q., Cruz-Martins, Natália, El-Saber Batiha, Gaber

Volltext

SIRT1 pathway in Parkinson’s disease: a faraway snapshot but so close von Batiha, Gaber El-Saber, Al-kuraishy, Hayder M., Al-Gareeb, Ali I., Elekhnawy, Engy

Volltext

High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons von Al-kuraishy, Hayder M., Al-Gareeb, Ali I., Alkazmi, Luay, Habotta, Ola A., Batiha, Gaber El-Saber

Volltext

Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals von Al-kuraishy, Hayder M., Batiha, Gaber El-Saber, Faidah, Hani, Al-Gareeb, Ali I., Saad, Hebatallah M., Simal-Gandara, Jesus

Volltext

Niclosamide for Covid-19: bridging the gap von Al-kuraishy, Hayder M., Al-Gareeb, Ali I., Alzahrani, Khalid J., Alexiou, Athanasios, Batiha, Gaber El-Saber

Volltext

SARS‐COV‐2 infection and Parkinson's disease: Possible links and perspectives von Al‐kuraishy, Hayder M., Al‐Gareeb, Ali I., Kaushik, Ajeet, Kujawska, Małgorzata, Ahmed, Eman A., Batiha, Gaber El‐Saber

Volltext

Nitazoxanide and COVID-19: A review von Al-kuraishy, Hayder M., Al-Gareeb, Ali I., Elekhnawy, Engy, Batiha, Gaber El-Saber

Volltext

COVID-19 and corticosteroids: a narrative review von El-Saber Batiha, Gaber, Al-Gareeb, Ali I., Saad, Hebatallah M., Al-kuraishy, Hayder M.

Volltext

Hemolytic anemia in COVID-19 von Al-kuraishy, Hayder M., Al-Gareeb, Ali I., Kaushik, Ajeet, Kujawska, Małgorzata, Batiha, Gaber El-Saber

Volltext

Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects von Al-kuraishy, Hayder M., Al-Gareeb, Ali I., Qusty, Naeem, Cruz-Martins, Natália, El-Saber Batiha, Gaber

Volltext

DPP-4 inhibitors and type 2 diabetes mellitus in Parkinson’s disease: a mutual relationship von Alrouji, Mohammed, Al-kuraishy, Hayder M., Al-buhadily, Ali K., Al-Gareeb, Ali I., Elekhnawy, Engy, Batiha, Gaber El-Saber

Volltext

Possible role of LCZ696 in atherosclerosis: new inroads and perspective von Al-kuraishy, Hayder M., Al-Gareeb, Ali I., Elekhnawy, Engy, Batiha, Gaber El-Saber

Volltext

Potential role of lipoxin in the management of COVID-19: a narrative review von Batiha, Gaber El-Saber, Al-Gareeb, Ali I., Elekhnawy, Engy, Al-kuraishy, Hayder M.

Volltext

Long-term use of metformin and Alzheimer’s disease: beneficial or detrimental effects von Al-kuraishy, Hayder M., Al-Gareeb, Ali I., Saad, Hebatallah M., Batiha, Gaber El-Saber

Volltext

Fenofibrate for COVID-19 and related complications as an approach to improve treatment outcomes: the missed key for Holy Grail von Alkhayyat, Shadi Salem, Al-kuraishy, Hayder M., Al-Gareeb, Ali I., El-Bouseary, Maisra M., AboKamer, Amal M., Batiha, Gaber El-Saber, Simal-Gandara, Jesus

Volltext

New insight on the potential detrimental effect of metabolic syndrome on the Alzheimer disease neuropathology: Mechanistic role von Ali, Naif H., Al‐Kuraishy, Hayder M., Al‐Gareeb, Ali I., Alexiou, Athanasios, Papadakis, Marios, Bahaa, Mostafa M., Alibrahim, Fawaz, Batiha, Gaber El‐Saber

Volltext

BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy von Ali, Naif H., Al‐Kuraishy, Hayder M., Al‐Gareeb, Ali I., Alexiou, Athanasios, Papadakis, Marios, AlAseeri, Ali Abdullah, Alruwaili, Mubarak, Saad, Hebatallah M., Batiha, Gaber El‐Saber

Volltext

Irisin/PGC-1α/FNDC5 pathway in Parkinson’s disease: truth under the throes von Ali, Naif H., Alhamdan, Nourah Ahmad, Al-kuraishy, Hayder M., Al-Gareeb, Ali I., Elekhnawy, Engy, Batiha, Gaber El-Saber

Volltext